Our portfolio
Abbott

Expanded rapid COVID-19 testing in LMICs

Abbott Laboratories received the foundation’s support to enable the distribution of its Panbio COVID-19 Ag Rapid Test in low- and middle-income countries. The availability of rapid diagnostic tests that are both cost-effective and produce results within 15–20 minutes is critical in combating the spread of the pandemic.
Website
  • Domain
    Healthcare Delivery
  • Investment type
    Volume guarantee
  • Status
    Exit
  • Initial investment
    Public
  • Partnered in
    2020
  • Investment lead
    Natalie Revelle
  • Headquarters
    USA
  • Program strategy
    COVID-19 Response

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.